Navigation Links
September 2009 Mayo Clinic Health Letter Highlights Snoring, Kidney Stones and Vitamin D
Date:9/16/2009

in D: Often consumed with calcium to help absorption, vitamin D may raise the risk of developing calcium-based stones. Vitamin D has many health benefits, but for those at risk of kidney stones, limiting vitamin D consumption to age-specific recommended daily limits may be advised.

Consider food choices: Limiting intake of oxalate-containing foods -- such as spinach, beets, chocolate, peanuts, potatoes and many other foods -- is an important preventive strategy for those with calcium oxalate stones who also have conditions that affect the small bowel, such as Crohn's disease. For those who don't have digestive conditions or high urine oxalate levels, the benefits of diet changes are unclear. Because the diet is very difficult to follow, Mayo Clinic experts don't emphasize this strategy.

Vitamin D: Many Benefits; Optimal Dose Uncertain

ROCHESTER, Minn. -- Vitamin D appears to boost health from head to toe, according to the September issue of Mayo Clinic Health Letter. But, so far, there's no consensus on what level of vitamin D is optimal for good health.

Recent reports on vitamin D suggest that it offers many benefits, especially for older adults. Findings point to improved balance, reduction in the risk of bone fractures, and better thinking skills such as planning, organizing and abstract thinking. Low levels of vitamin D are associated with diabetes, cardiovascular disease, multiple sclerosis and other autoimmune disorders, infections such as tuberculosis, and periodontal disease. Low vitamin D levels also may affect certain cancers, including colon, breast and prostate cancers.

Vitamin D is the only vitamin that the body can manufacture itself. The only requirement is sunshine, specifically ultraviolet B rays. About 10 to 15 minutes of exposure two to three times a week during nonpeak sun hours is considered adequate. But the sunshine approach doesn't
'/>"/>

SOURCE Mayo Clinic
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
2. Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
3. Mega Events in September Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month
4. September: Time to Try Cholesterol-Free Soyfoods
5. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
6. AMN Healthcare Services to Host Analyst Day on Tuesday, September 18, 2007
7. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
8. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
9. West Coast Bank Will Sponsor the Doernbecher Freestyle on September 22, 2007
10. On September 7th Local Organizations Partner to Celebrate Healthy Steps
11. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... According to the the Stevens Johnson Syndrome Foundation, Stevens ... a severe allergic reaction usually to medicine (i). The ... quickly advance causing blistering and large areas of dead skin. ... can develop at any time and seriously affect both children ... Bol, passed away after he received kidney medicine which caused ...
(Date:5/18/2013)... 2013 The product liability attorneys at Wright ... behalf of consumers nationwide who have sustained serious tendon injuries ... These cases are all part of MDL 2308 and were ... will be heard in the U.S. District Court of ... & Schulte, LLC specializes in defending the rights of those ...
(Date:5/17/2013)... 17, 2013 Daily Gossip announced on Monday ... creator of the Program Yourself Thin regime, Jim ... online website by the end of the month in order ... successfully reeducate themselves and lead a healthy lifestyle, free of ... Thin package is available for only $97 and it ...
(Date:5/17/2013)... 17, 2013 Degenerative changes to the area ... felt with compression, known as the nucleus pulposus, has been ... a new study led by researchers at the Icahn School ... the journal PLOS ONE, reinforces the importance of diabetes in ... it is the first study to demonstrate that these changes ...
(Date:5/17/2013)... York, New York (PRWEB) May 17, 2013 ... firm dedicated to protecting the rights of victims injured ... (J&J)’s DePuy Orthopaedics Inc. has said in a May ... selling some of its metal-on-metal and ceramic-on-metal hip replacement ... Articulation and the Complete Ceramic-on-Metal Acetabular Hip System will ...
Breaking Medicine News(10 mins):Health News:Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 3Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 4Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 2Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 3Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 4Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 2Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 3
... TAMPA, Fla., Nov. 2 Romark Laboratories, ... phase II clinical trial showing that 79% of ... nitazoxanide plus,the standard of care had a sustained ... weeks following treatment, compared to 43%,of patients receiving ...
... Kensey Nash Corporation,(Nasdaq: KNSY ) today ... Optical Coherence Domain Reflectometry Guidewire, from Lawrence,Livermore National ... related to its chronic total occlusion (CTO) platform.,The ... capabilities,allowing it to sense locations, thickness, and structure ...
... Amedisys, Inc.,(Nasdaq: AMED or the "Company"), one of America,s ... Graham, President and,Chief Operating Officer, and Dale E. Redman, ... Markets 18th Annual Healthcare Conference in,New York on Tuesday, ... 9:10 a.m. Eastern time. The audio,presentation will be webcast ...
... Nov. 2 NxStage Medical, Inc.,(Nasdaq: NXTM ), ... machine, today announced its financial results for the,third quarter ... quarter of 2007 were $11.6 million, compared to,$5.5 million ... 111%. Revenues in,the chronic home dialysis market were $8.3 ...
... 2 Vista Partners announced,today that it has ... RPTP). "We believe Raptor,s operational approach will serve,as ... as it promotes,operational efficiency, reduced operating costs and ... a Phase II candidate for 2008 in,Convivia(TM), which ...
... (Nasdaq: KOSN ) will announce its third ... after market close. The announcement of Kosan,s ... a conference call and live webcast on November ... Eastern. Interested parties may access the,live call by ...
Cached Medicine News:Health News:Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C 2Health News:Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C 3Health News:Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C 4Health News:Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform 2Health News:Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform 3Health News:Amedisys to Present at 2007 CIBC Healthcare Conference in New York 2Health News:NxStage Medical Reports Third Quarter 2007 Results 2Health News:NxStage Medical Reports Third Quarter 2007 Results 3Health News:NxStage Medical Reports Third Quarter 2007 Results 4Health News:NxStage Medical Reports Third Quarter 2007 Results 5Health News:NxStage Medical Reports Third Quarter 2007 Results 6Health News:NxStage Medical Reports Third Quarter 2007 Results 7Health News:NxStage Medical Reports Third Quarter 2007 Results 8Health News:Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp. 2Health News:Kosan Announces November 8, 2007 Conference Call and Webcast of Third Quarter 2007 Financial Results 2
(Date:5/17/2013)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... systems, announced today that the United States Food and ... Drug application(IND) for ORMD-0801, its oral insulin capsule. ... clearance to proceed," stated Nadav Kidron ... major milestone for Oramed and we look forward to ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... Technology and Research (A*STAR) and Switzerland,s ... has been dosed in a Phase 1 clinical trial with ... Qbeta virus-like particle (VLP) technology. In this first Phase 1 ... candidate and its potential to protect against H1N1 influenza infection ...
(Date:5/16/2013)... Therapeutics, (Nasdaq: NKTR ) President and Chief Executive ... to present at the upcoming 2013 UBS Global Healthcare Conference ... New York Hotel on Tuesday, May 21, 2013 at 10:00 ... via a Webcast through a link posted in the Investor ... . This Webcast will be available for replay until June ...
Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... Inc. (NYSE: WLP ) announced today that ... the Centers for Medicare & Medicaid Services (CMS) to ... (DME MAC) for Jurisdiction B, which includes the states ... National Government Services was originally awarded ...
... Inc. (OTC Bulletin Board: AEMD ), ... address infectious disease and cancer, disclosed today that ... Hemopurifier® within U.S. Government programs that support the ... threats. The Aethlon Hemopurifier® is the first medical ...
Cached Medicine Technology:WellPoint Subsidiary Wins Durable Medical Equipment Medicare Administrative Contract Valued at $86.7 Million 2Aethlon Medical Reestablishes Biodefense Programs 2Aethlon Medical Reestablishes Biodefense Programs 3Aethlon Medical Reestablishes Biodefense Programs 4Aethlon Medical Reestablishes Biodefense Programs 5Aethlon Medical Reestablishes Biodefense Programs 6
60 month warranty, constructed entirely of aluminum alloy, allows the selection of 11 units of measure....
Inquire...
Thermometer for Round Water Bath...
... The F340 is a basic laboratory system ... pH results can be obtained when used ... 3-in-1 electrode. • Fast and easy one ... recognition for five buffers (pH 1.68, 4.00, ...
Medicine Products: